Filing Flows › Chemed (CHE) › Q3 2025
Chemed (CHE) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 31, 2025
Chemed (CHE) reported revenue of $625M for the third quarter 2025 (Q3 2025), +3% from a year earlier and +1% from the quarter before. Operating margin was 12.0%, net earnings $64.2M (10.3% of revenue).
Chemed, Q3 2025: revenue $625M (+3% year over year), operating margin 12.0%, net earnings $64.2M, operating cash flow $83.4M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $625M | +1% | +3% |
| Operating profit | $74.8M | +10% | -19% |
| Net earnings | $64.2M | +22% | -15% |
| Operating cash flow | $83.4M | -40% | -8% |
| Free cash flow | $65.9M | -46% | -8% |
What changed
Revenue was $624.9M in Q3 2025, up 3% year over year and up 1% from the previous quarter. VITAS was the largest line at 65% of revenue. VITAS added $16.3M year over year (up 4%), 87% of the total change.
Operating profit was $74.8M, a 12.0% margin (down 3.2 points year over year). Operating profit fell $17.4M even though revenue rose $18.7M versus a year earlier, so costs grew faster than sales. Total costs grew 7% against revenue growth of 3%. The fastest-growing cost line was Other operating costs (+21%). Net earnings were $64.2M, down 15% year over year. The effective tax rate was 23.1%.
Operating cash flow was $83.4M (down 8% year over year), 130% of net earnings. Non-cash charges added back $16.2M of depreciation and amortization. Capital expenditures of $17.5M left free cash flow of $65.9M.
Questions
What was Chemed's revenue in the third quarter 2025?
Chemed (CHE) reported revenue of $625M for the third quarter 2025 (Q3 2025), +3% from a year earlier and +1% from the quarter before.
Was Chemed profitable in the third quarter 2025?
Operating profit was $74.8M (12.0% of revenue) and net earnings $64.2M.
Source: Chemed 10-Q on SEC EDGAR.